Autolus Therapeutics plc
AUTL
$2.12
-$0.11-4.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.74% | -14.18% | -65.10% | 31.70% | -154.15% |
| Total Depreciation and Amortization | 2.58% | 3.66% | 7.18% | 4.00% | 9.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.56% | -7.77% | 588.16% | -143.00% | 206.36% |
| Change in Net Operating Assets | -1,778.94% | 107.96% | 46.11% | -29.50% | -492.73% |
| Cash from Operations | 2.98% | 0.85% | 6.71% | 3.68% | -99.20% |
| Capital Expenditure | -403.73% | 120.08% | 39.43% | 11.72% | 25.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 15.39% | 114.39% | -61.28% | 301.14% | 86.23% |
| Cash from Investing | 11.10% | 143.46% | -62.94% | 261.07% | 84.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.75% | -1.30% | -130.99% | -- | -- |
| Cash from Financing | -14.75% | -1.30% | -130.99% | -- | -- |
| Foreign Exchange rate Adjustments | -437.69% | 116.44% | -162.69% | 60.62% | 109.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.70% | 147.77% | -234.29% | 121.35% | 69.39% |